Keyphrases
3-deoxyanthocyanidins
10%
Anthelmintic Efficacy
10%
Benzoyl
10%
Cattle
15%
CD8+ T Cells
21%
Choline
11%
Cryptosporidiosis
16%
Cryptosporidium
20%
Cryptosporidium Parvum
58%
Cyclospora Cayetanensis
10%
Epitope
12%
Goat
19%
H. Contortus
11%
Haemonchus Contortus
11%
Human Malaria Parasites
22%
IC50
11%
Immunization
12%
In Vitro Activity
10%
In Vivo Efficacy
12%
Infectivity
10%
Knockdown
15%
Lactate Dehydrogenase
13%
Lewis Rats
10%
Molecular Targets
13%
N-hydroxybenzamides
10%
Oocyst
19%
Parvum
42%
PfPMT
11%
Phosphatidylcholine
14%
Phosphatidylethanolamine N-methyltransferase
39%
Plasmodium Falciparum
44%
Potential Treatments
10%
Programmed Cell Death
10%
Pyrimethamine
10%
Serine Decarboxylase
11%
Sorghum Bicolor
10%
Stem Cell-derived
13%
Supertype
10%
T. Brucei
12%
T. Evansi
22%
T. Gondii Infection
13%
Tachyzoite
11%
Toxoplasma Gondii (T. gondii)
100%
Toxoplasma Gondii Infection
11%
Toxoplasmosis
18%
Trypanosoma Brucei
12%
Trypanosoma Congolense
15%
Trypanosoma Evansi
36%
Trypanosome
23%
Trypanosomosis
11%
Immunology and Microbiology
Adjuvant
15%
Antisense
9%
Apicomplexa
7%
Cell Culture
12%
Cell Cycle Arrest
10%
Cell Cycle Checkpoint
10%
Cell Death
13%
Cell Line
8%
Cryptosporidium
32%
Cryptosporidium parvum
58%
Cyclospora cayetanensis
10%
Cytotoxic T-Cell
17%
Cytotoxicity
9%
Drug Resistance
10%
Energy Yield
7%
Epitope
22%
Feces
7%
Gene Knockdown
7%
Genetic Variability
11%
Growth, Development and Aging
10%
Haemonchus contortus
11%
Host Cell
14%
IC50
20%
Infectious Agent
8%
interferon
8%
Intracellular Parasite
10%
Lewis Rat
10%
Life Cycle
13%
Methylation
11%
Nematode
14%
Oocyst
32%
Parasite Load
12%
Parasitic Nematodes
7%
Peptides
24%
Plasmodium
32%
Plasmodium falciparum
34%
Prevalence
18%
Protozoa
22%
Serine
14%
Stem Cell
13%
Tachyzoite
8%
Toxoplasma gondii
54%
Toxoplasmosis
41%
Transgenics
10%
Trypanosoma
23%
Trypanosoma Brucei
12%
Trypanosoma Congolense
10%
Trypanosoma evansi
31%
Upregulation
8%
Zoonotic
8%